AlphaMadera's AlphaVal page classifies RXO, Inc. as a Cyclical & Capital-Intensive business and values it using Normalized Earnings × Cycle Multiple, then compares the result to the current market price to flag RXO as undervalued, fairly valued, or overvalued.

What is RXO, Inc.'s fair value?

Fair value for RXO comes from a Normalized Earnings × Cycle Multiple model -- the approach AlphaVal selected for this company's Cyclical & Capital-Intensive classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value RXO?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. RXO was classified as Cyclical & Capital-Intensive and is valued using Normalized Earnings × Cycle Multiple, built from RXO's most recent reported fundamentals.

RXO - RXO, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $26.11 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong

Trading 2199.4% above fair value

Current Price $28.67

Bear Case $0.91 96.8% downside ($0.91 - $28.67) / $28.67 = -96.8% $0.23 × 4x

Fair Value $1.25 95.7% downside ($1.25 - $28.67) / $28.67 = -95.7% $0.23 × 6x

Bull Case $1.59 94.5% downside ($1.59 - $28.67) / $28.67 = -94.5% $0.23 × 7x

Adjust Assumptions

Cycle P/E Multiple

5.5x

Normalized EPS

0.23$

Key Value Driver

Through-cycle normalized EPS ($0.23)

Terminal Value % of EV

Implied Market Multiple 126.5x

Market is pricing in (growth)

Plain-Language Summary

Using 7-year normalized EPS of $0.23 at a 6x cycle multiple, the base-case value is $1.25 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (21 analysts) $26.11

Analyst Range $18.00 – $31.00

Divergence from AlphaVal 95%

Warnings

⚠ This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.

ℹ Wall Street's average price target is $26.11 (from 21 analysts). Our estimate is 95% below the consensus -- consider that gap carefully.

Key Risks

Standard 10-year DCF produces unreliable terminal values for cyclicals
'Cheap' P/E at cycle peak is the most common value trap — normalize first
Captive finance subsidiaries have different risk profiles from manufacturing